Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein.
Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein. J Infect Dis. 2014 Apr 01; 209(7):1116-25.
View in:
PubMed
subject areas
Animals
Animals
Antibodies, Bacterial
Antibodies, Bacterial
Bacterial Proteins
Bacterial Proteins
Carrier State
Carrier State
Cross Protection
Cross Protection
Disease Models, Animal
Disease Models, Animal
Female
Female
Haemophilus influenzae
Haemophilus influenzae
Mice
Mice
Mice, Inbred BALB C
Mice, Inbred BALB C
Neisseria meningitidis
Neisseria meningitidis
Pneumococcal Infections
Pneumococcal Infections
Pneumococcal Vaccines
Pneumococcal Vaccines
Recombinant Fusion Proteins
Recombinant Fusion Proteins
Streptococcus pneumoniae
Streptococcus pneumoniae
Streptolysins
Streptolysins
Toxoids
Toxoids
Vaccines, Synthetic
Vaccines, Synthetic
authors with profiles
Rodney Kim Tweten